Roeschert, I;
Poon, E;
Henssen, AG;
Garcia, HD;
Gatti, M;
Giansanti, C;
Jamin, Y;
... Eilers, M; + view all
(2021)
Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma.
Nature Cancer
, 2
pp. 312-326.
10.1038/s43018-020-00171-8.
Preview |
Text
EMS116978.pdf - Accepted Version Download (6MB) | Preview |
Abstract
Amplification of MYCN is the driving oncogene in a subset of high-risk neuroblastoma. The MYCN protein and the Aurora-A kinase form a complex during S phase that stabilizes MYCN. Here we show that MYCN activates Aurora-A on chromatin, which phosphorylates histone H3 at serine 10 in S phase, promotes the deposition of histone H3.3 and suppresses R-loop formation. Inhibition of Aurora-A induces transcription-replication conflicts and activates the Ataxia telangiectasia and Rad3 related (ATR) kinase, which limits double-strand break accumulation upon Aurora-A inhibition. Combined inhibition of Aurora-A and ATR induces rampant tumor-specific apoptosis and tumor regression in mouse models of neuroblastoma, leading to permanent eradication in a subset of mice. The therapeutic efficacy is due to both tumor cell-intrinsic and immune cell-mediated mechanisms. We propose that targeting the ability of Aurora-A to resolve transcription-replication conflicts is an effective therapy for MYCN-driven neuroblastoma (141 words).
Type: | Article |
---|---|
Title: | Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/s43018-020-00171-8 |
Publisher version: | https://doi.org/10.1038/s43018-020-00171-8 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept |
URI: | https://discovery.ucl.ac.uk/id/eprint/10137684 |
Archive Staff Only
View Item |